Top

Reactions Weekly

Published in:

01-05-2022 | Cerebral Metastase | Case report

Atezolizumab

Immune thyroiditis and primary hypothyroidism: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Amir H, et al. Abstract #1153565: Late manifestation of hypothyroidism due to thyroiditis with elevated auto-antibody titers in a patient on immune checkpoint inhibitor therapy. Endocrine Practice 28 (Suppl.): S127-S128, No. 5, May 2022. Available from: URL: http://doi.org/10.1016/j.eprac.2022.03.298 [abstract]

Title: Atezolizumab
Immune thyroiditis and primary hypothyroidism: case report
Publication date: 01-05-2022
Publisher: Springer International Publishing
Keywords: Cerebral Metastase
Thyroiditis
Hypothyroidism
Levothyroxine
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-15814-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Atezolizumab

Immune thyroiditis and primary hypothyroidism: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Nivolumab

Dapsone/ofloxacin/rifampicin

Erlotinib

Hydrochlorothiazide

Atezolizumab/bevacizumab

Multiple drugs